David Schmidt Named Chief Commercial Officer at Curiteva

Curiteva has welcomed a new C-Suite member, appointing David Schmidt as chief commercial officer. 

“David is a talented, and experienced leader and we are honored to have him join our executive leadership team,” Curiteva Board Chair Chad Falciani said. “His history of selling disruptive technologies, coupled with professional sales methods, aligns perfectly with our vision.”
 
Schmidt began his career with a startup and helped introduce one of the first-ever interbody fusion implants, a milestone in spinal treatment. After spending years as a successful spine implant distributor, Schmidt embarked on a 20-year tenure with Medtronic, assuming leadership roles whereby he managed enabling technology sales for the eastern half of the United States. Following his tenure at Medtronic, Schmidt worked for Wright Medical, leading a team to drive sales in the foot and ankle market. Most recently, he spearheaded sales and marketing initiatives for a small spine company. 
 
“Curiteva embodies the value of innovation, leadership, and commitment to transforming patient care and I am excited to embark on this journey with Curiteva. After learning about the Inspire Technology and seeing some of the early clinical data to support it, I am eager to leverage my experience in commercial strategy to further Curiteva’s impact in the healthcare landscape,” Schmidt stated.
 
Curiteva is a privately held technology and manufacturing company based in Huntsville, Ala. The company is pioneering 3D printing of Trabecular PEEK implants with a bioactive nano-surface to improve the ways in which engineered structures and implant biomaterials accelerate immunomodulation, enhance healing, and improve patient outcomes.